A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults

NCT05274659 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: KJ103
DRUG: Placebo

Sponsor

Shanghai Bao Pharmaceuticals Co., Ltd.